MR imaging and proton spectroscopy of the breast: How to select the images useful to convey the diagnostic message;RM mammaria (imaging e spettroscopia): Come selezionare le immagini utili alla trasmissione del messaggio diagnostico

Radiologia Medica

Volumn 112, Issue 7, 2007, Pages 1060-1068

  Fausto, A ^a   Magaldi, A ^a   Babaei Paskeh, B ^a   Menicagli, L ^a   Lupo, E N ^a   Sardanelli, F ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Breast; Magnetic resonance (MR) imaging; Magnetic resonance (MR) spectroscopy

Indexed keywords

GADOTERIC ACID;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST EXAMINATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; AGED; BREAST NEOPLASMS; CD-ROM; CONTRAST MEDIA; FEMALE; FOURIER ANALYSIS; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MAMMOGRAPHY; PROTONS; ULTRASONOGRAPHY, MAMMARY;

EID: 35848960592     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-007-0193-x     Document Type: Article

References (12)

1. Sardanelli F, Iozzelli A, Fausto A (2003) MR imaging of the breast: indications, established technique, and new directions. Eur Radiol 13(Suppl 3):N28-N36.
2. Baum F, Fischer U, Vosshenrich R, Grabbe E (2002) Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol 12:1087-1892.
3. Katz-Brull R, Lavin PT, Lenkinski RE (2002) Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 9:1197-1203.
4. Huang W, Fisher PR, Dulaimy K, Tudorica LA, O'Hea B, Button TM (2004) Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 232:585-591.
5. Stanwell P, Gluch L, Clark D, et al. (2005) Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T. Eur Radiol 15:1037-1043.
6. Bartella L, Morris EA, Dershaw DD, et al. (2006) Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology 239:686-692.
7. Mankovich NJ, Robertson DR, Cheeseman AM (1990) Three-dimensional image display in medicine. J Digit Imaging 3:69-80.
8. Perrone L, Politi M, Foschi R (2003) Postprocessing of digital images. Rays 28:95-101.
9. Duan SY, Zhang DT, Lin QC, Wu YH (2006) Clinical value of CT three-dimensional imaging in diagnosing gastrointestinal tract diseases. World J Gastroenterol 12:2945-2948.
10. Sardanelli F, Fausto A, Iozzelli A, Rescinito G, Calabrese M (2004) Dynamic breast magnetic resonance imaging: effect of changing the region of interest on early enhancement using 2D and 3D techniques. J Comput Assist Tomogr 28:642-646.
11. Mahfouz AE, Sherif H, Saad A, et al. (2001) Gadolinium-enhanced MR angiography of the breast: is breast cancer associated with ipsilateral higher vascularity? Eur Radiol 11:965-969.
12. Sardanelli F, Iozzelli A, Fausto A, Carriero A, Kirchin MA (2005) Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology 235:791-797.